RNA interference against viruses: strike and counterstrike (original) (raw)

• Bitko, V. & Barik, S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1, 34 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Haasnoot, P.C.J. & Berkhout, B. RNA interference: its use as antiviral therapy. in Handbook of Experimental Pharmacology Vol. 173, 117–150 (Springer, Berlin and Heidelberg, 2006).
  Google Scholar
• Coburn, G.A. & Cullen, B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76, 9225–9231 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Jacque, J.M., Triques, K. & Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 418, 435–438 (2002).
  Article CAS PubMed Google Scholar
• Lee, N.S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500–505 (2002).
  Article CAS PubMed Google Scholar
• Novina, C.D. et al. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8, 681–686 (2002).
  Article CAS PubMed Google Scholar
• Qin, X.F., An, D.S., Chen, I.S.Y. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100, 183–188 (2003).
  Article CAS PubMed Google Scholar
• Kronke, J. et al. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J. Virol. 78, 3436–3446 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Yokota, T. et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4, 602–608 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• McCaffrey, A.P. et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21, 639–644 (2003).
  Article PubMed Google Scholar
• Shlomai, A. & Shaul, Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37, 764–770 (2003).
  Article CAS PubMed Google Scholar
• He, M.L. et al. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. J. Am. Med. Assoc. 290, 2665–2666 (2003).
  Article CAS Google Scholar
• Li, B.J. et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11, 944–951 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ge, Q. et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA 100, 2718–2723 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kurreck, J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270, 1628–1644 (2003).
  Article CAS PubMed Google Scholar
• Larsen, H.J., Bentin, T. & Nielsen, P.E. Antisense properties of peptide nucleic acid. Biochim. Biophys. Acta 1489, 159–166 (1999).
  Article CAS PubMed Google Scholar
• Petersen, M. & Wengel, J. LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol. 21, 74–81 (2003).
  Article CAS PubMed Google Scholar
• Iversen, P.L. Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivation. Curr. Opin. Mol. Ther. 3, 235–238 (2001).
  CAS PubMed Google Scholar
• Jakobsen, M.R., Haasnoot, J., Wengel, J., Berkhout, B. & Kjems, J. Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites. Retrovirology 4, 29 (2007).
  Article PubMed PubMed Central Google Scholar
• Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
  Article CAS PubMed Google Scholar
• Leung, A.K. & Sharp, P.A. microRNAs: a safeguard against turmoil? Cell 130, 581–585 (2007).
  Article CAS PubMed Google Scholar
• Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495–500 (2005).
  Article CAS PubMed Google Scholar
• Brennecke, J., Stark, A., Russell, R.B. & Cohen, S.M. Principles of microRNA-target recognition. PLoS Biol. 3, e85 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91–105 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. & Burge, C.B. Prediction of mammalian microRNA targets. Cell 115, 787–798 (2003).
  Article CAS PubMed Google Scholar
• Waterhouse, P.M., Wang, M.B. & Lough, T. Gene silencing as an adaptive defence against viruses. Nature 411, 834–842 (2001).
  Article CAS PubMed Google Scholar
• Voinnet, O. RNA silencing as a plant immune system against viruses. Trends Genet. 17, 449–459 (2001).
  Article CAS PubMed Google Scholar
• Wilkins, C. et al. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 436, 1044–1047 (2005).
  Article CAS PubMed Google Scholar
• Wang, X.H. et al. RNA interference directs innate immunity against viruses in adult Drosophila. Science 312, 452–454 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Segers, G.C., Zhang, X., Deng, F., Sun, Q. & Nuss, D.L. Evidence that RNA silencing functions as an antiviral defense mechanism in fungi. Proc. Natl. Acad. Sci. USA 104, 12902–12906 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Haasnoot, P.C.J., Cupac, D. & Berkhout, B. Inhibition of virus replication by RNA interference. J. Biomed. Sci. 10, 607–616 (2003).
  Article PubMed Google Scholar
• Bennasser, Y., Le, S.Y., Benkirane, M. & Jeang, K.T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22, 607–619 (2005).
  Article CAS PubMed Google Scholar
• Cullen, B.R. Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat. Immunol. 7, 563–567 (2006).
  Article CAS PubMed Google Scholar
• Berkhout, B. & Jeang, K.T. RISCy business: microRNAs, pathogenesis, and viruses. J. Biol. Chem. 282, 26641–26645 (2007).
  Article CAS PubMed Google Scholar
• Lecellier, C.H. et al. A cellular microRNA mediates antiviral defense in human cells. Science 308, 557–560 (2005).
  Article CAS PubMed Google Scholar
• Otsuka, M. et al. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27, 123–134 (2007).
  Article CAS PubMed Google Scholar
• Huang, J. et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes. Nat. Med. 13, 1241–1247 (2007).
  Article CAS PubMed Google Scholar
• Yeung, M.L. et al. Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2, 81 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sijen, T. & Plasterk, R.H. Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature 426, 310–314 (2003).
  Article CAS PubMed Google Scholar
• Soifer, H.S., Zaragoza, A., Peyvan, M., Behlke, M.A. & Rossi, J.J. A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res. 33, 846–856 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, N. & Kazazian, H.H. Jr . L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat. Struct. Mol. Biol. 13, 763–771 (2006).
  Article CAS PubMed Google Scholar
• Cullen, B.R. Viruses and microRNAs. Nat. Genet. 38 (Suppl.), S25–S30 (2006).
  Article CAS PubMed Google Scholar
• Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M. & Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577–1581 (2005).
  Article CAS PubMed Google Scholar
• Cai, X. et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2, e23 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, C. et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80, 5499–5508 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Grundhoff, A., Sullivan, C.S. & Ganem, D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12, 733–750 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Pfeffer, S. et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2, 269–276 (2005).
  Article CAS PubMed Google Scholar
• Pfeffer, S. et al. Identification of virus-encoded microRNAs. Science 304, 734–736 (2004).
  Article CAS PubMed Google Scholar
• Gupta, A., Gartner, J.J., Sethupathy, P., Hatzigeorgiou, A.G. & Fraser, N.W. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442, 82–85 (2006).
  Article CAS PubMed Google Scholar
• Sullivan, C.S., Grundhoff, A.T., Tevethia, S., Pipas, J.M. & Ganem, D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435, 682–686 (2005).
  Article CAS PubMed Google Scholar
• Li, F. & Ding, S.W. Virus counterdefense: diverse strategies for evading the RNA-silencing immunity. Annu. Rev. Microbiol. 60, 503–531 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Andersson, M.G. et al. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 79, 9556–9565 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Haasnoot, J. et al. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3, e86 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Li, W.X. et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. USA 101, 1350–1355 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, S. & Cullen, B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J. Virol. 78, 12868–12876 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 130, 883–892 (2006).
  Article CAS PubMed Google Scholar
• Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  Article CAS PubMed Google Scholar
• Morrissey, D.V. et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23, 1002–1007 (2005).
  Article CAS PubMed Google Scholar
• Morrissey, D.V. et al. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41, 1349–1356 (2005).
  Article CAS PubMed Google Scholar
• Rana, T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8, 23–36 (2007).
  Article CAS PubMed Google Scholar
• Czauderna, F. et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705–2716 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Layzer, J.M. et al. In vivo activity of nuclease-resistant siRNAs. RNA 10, 766–771 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553 (2002).
  Article CAS PubMed Google Scholar
• Boden, D. et al. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res. 32, 1154–1158 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Du, G., Yonekubo, J., Zeng, Y., Osisami, M. & Frohman, M.A. Design of expression vectors for RNA interference based on miRNAs and RNA splicing. FEBS J. 273, 5421–5427 (2006).
  Article CAS PubMed Google Scholar
• Silva, J.M. et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 37, 1281–1288 (2005).
  Article CAS PubMed Google Scholar
• Lo, H.L. et al. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene Ther. 14, 1503–1512 (2007).
  Article CAS PubMed Google Scholar
• Akashi, H. et al. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol. Biosyst. 1, 382–390 (2005).
  Article CAS PubMed Google Scholar
• Konstantinova, P. et al. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther. 13, 1403–1413 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Y.P., Haasnoot, J. & Berkhout, B. Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res. (2007).
• Nishitsuji, H., Kohara, M., Kannagi, M. & Masuda, T. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. J. Virol. 80, 7658–7666 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Watanabe, T. et al. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther. 13, 883–892 (2006).
  Article CAS PubMed Google Scholar
• Weinberg, M.S. et al. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol. Ther. 15, 534–541 (2007).
  Article CAS PubMed Google Scholar
• Boden, D., Pusch, O., Lee, F., Tucker, L. & Ramratnam, B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77, 11531–11535 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, J.A. & Richardson, C.D. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J. Virol. 79, 7050–7058 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, H.L. et al. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 128, 708–716 (2005).
  Article CAS PubMed Google Scholar
• Gitlin, L., Stone, J.K. & Andino, R. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79, 1027–1035 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kusov, Y., Kanda, T., Palmenberg, A., Sgro, J.Y. & Gauss-Muller, V. Silencing of hepatitis A virus infection by small interfering RNAs. J. Virol. 80, 5599–5610 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Das, A.T. et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78, 2601–2605 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Arrighi, J.F. et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200, 1279–1288 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, S. et al. Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res. 32, 3752–3759 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ping, Y.H. et al. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology 1, 46 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, N., Fang, J., Mukhtar, M., Acheampong, E. & Pomerantz, R.J. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Gene Ther. 11, 1703–1712 (2004).
  Article CAS PubMed Google Scholar
• Samson, M. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725 (1996).
  Article CAS PubMed Google Scholar
• Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377 (1996).
  Article CAS PubMed Google Scholar
• Triboulet, R. et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315, 1579–1582 (2007).
  Article CAS PubMed Google Scholar
• Morris, K.V., Chan, S.W., Jacobsen, S.E. & Looney, D.J. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305, 1289–1292 (2004).
  Article CAS PubMed Google Scholar
• Han, J., Kim, D. & Morris, K.V. Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc. Natl. Acad. Sci. USA 104, 12422–12427 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Weinberg, M.S. et al. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 12, 256–262 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Haraguchi, T. et al. SiRNAs do not induce RNA-dependent transcriptional silencing of retrovirus in human cells. FEBS Lett. 581, 4949–4954 (2007).
  Article CAS PubMed Google Scholar
• Ge, Q. et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101, 8676–8681 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bitko, V., Musiyenko, A., Shulyayeva, O. & Barik, S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11, 50–55 (2005).
  Article PubMed Google Scholar
• Zhang, W. et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11, 56–62 (2005).
  Article CAS PubMed Google Scholar
• Rossi, J.J. RNAi as a treatment for HIV-1 infection. Biotechniques 40 (Suppl.), 25–29 (2006).
  Article CAS Google Scholar
• Westerhout, E.M., Ooms, M., Vink, M., Das, A.T. & Berkhout, B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33, 796–804 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ter Brake, O., Konstantinova, P., Ceylan, M. & Berkhout, B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 14, 883–892 (2006).
  Article CAS PubMed Google Scholar
• van der Hoek, L. et al. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase. J. Virol. 79, 3536–3543 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Grimm, D. & Kay, M.A. Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol. Ther. 15, 878–888 (2007).
  Article CAS PubMed Google Scholar
• Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263–264 (2003).
  Article CAS PubMed Google Scholar
• Jackson, A.L. & Linsley, P.S. Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20, 521–524 (2004).
  Article CAS PubMed Google Scholar
• Grimm, D. et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441, 537–541 (2006).
  Article CAS PubMed Google Scholar
• Wang, M.B. et al. On the role of RNA silencing in the pathogenicity and evolution of viroids and viral satellites. Proc. Natl. Acad. Sci. USA 101, 3275–3280 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Itaya, A. et al. A structured viroid RNA serves as a substrate for dicer-like cleavage to produce biologically active small RNAs but is resistant to RNA-induced silencing complex-mediated degradation. J. Virol. 81, 2980–2994 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Flores, R. et al. Viroids: the minimal non-coding RNAs with autonomous replication. FEBS Lett. 567, 42–48 (2004).
  Article CAS PubMed Google Scholar
• Chang, J. & Taylor, J.M. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J. Virol. 77, 9728–9731 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, H. et al. Structure of an RNA hairpin from HRV-14. Biochemistry 40, 8055–8064 (2001).
  Article CAS PubMed Google Scholar
• Rohll, J.B. et al. The 5′-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J. Virol. 68, 4384–4391 (1994).
  CAS PubMed PubMed Central Google Scholar
• Rohll, J.B., Moon, D.H., Evans, D.J. & Almond, J.W. The 3′ untranslated region of picornavirus RNA: features required for efficient genome replication. J. Virol. 69, 7835–7844 (1995).
  CAS PubMed PubMed Central Google Scholar
• Hu, W.Y., Myers, C.P., Kilzer, J.M., Pfaff, S.L. & Bushman, F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 12, 1301–1311 (2002).
  Article CAS PubMed Google Scholar
• Capodici, J., Kariko, K. & Weissman, D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169, 5196–5201 (2002).
  Article PubMed Google Scholar
• Surabhi, R.M. & Gaynor, R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76, 12963–12973 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Nishitsuji, H. et al. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes Infect. 6, 76–85 (2004).
  Article CAS PubMed Google Scholar
• Joshi, P.J., North, T.W. & Prasad, V.R. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol. Ther. 11, 677–686 (2005).
  Article CAS PubMed Google Scholar
• Westerhout, E.M., Ter Brake, O. & Berkhout, B. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology 3, 57–65 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Albertini, A.A. et al. Crystal structure of the rabies virus nucleoprotein-RNA complex. Science 313, 360–363 (2006).
  Article CAS PubMed Google Scholar
• Green, T.J., Zhang, X., Wertz, G.W. & Luo, M. Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science 313, 357–360 (2006).
  Article CAS PubMed Google Scholar
• Fields, B.N., Raine, C.S. & Baum, S.G. Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virol. 43, 569–578 (1971).
  Article CAS Google Scholar
• Kobayashi, T., Chappell, J.D., Danthi, P. & Dermody, T.S. Gene-specific inhibition of reovirus replication by RNA interference. J. Virol. 80, 9053–9063 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Geiss, B.J., Pierson, T.C. & Diamond, M.S. Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. Virol. J. 2, 53 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Schubert, S. et al. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs. Antiviral Res. 73, 197–205 (2007).
  Article CAS PubMed Google Scholar
• Egger, D., Teterina, N., Ehrenfeld, E. & Bienz, K. Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J. Virol. 74, 6570–6580 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Van Aerschot, A. Oligonucleotides as antivirals: dream or realistic perspective? Antiviral Res. 71, 307–316 (2006).
  Article CAS PubMed Google Scholar
• Neuman, B.W. et al. Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. J. Virol. 79, 9665–9676 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Matzen, K. et al. RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides. Nat. Biotechnol. 25, 669–674 (2007).
  Article CAS PubMed Google Scholar
• Ter Brake, O. & Berkhout, B. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. J. RNAi Gene Silencing 1, 56–65 (2005).
  CAS PubMed PubMed Central Google Scholar
• Vitravene Study Group. Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. Am. J. Ophthalmol. 133, 484–498 (2002).
• Vitravene Study Group. Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS. Am. J. Ophthalmol. 133, 475–483 (2002).
• Vitravene Study Group. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am. J. Ophthalmol. 133, 467–474 (2002).
• Amado, R.G. et al. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum. Gene Ther. 15, 251–262 (2004).
  Article CAS PubMed Google Scholar
• Macpherson, J.L. et al. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients. J. Gene Med. 7, 552–564 (2005).
  Article CAS PubMed Google Scholar
• Levine, B.L. et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA 103, 17372–17377 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ranga, U. et al. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc. Natl. Acad. Sci. USA 95, 1201–1206 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Woffendin, C., Ranga, U., Yang, Z., Xu, L. & Nabel, G.J. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. USA 93, 2889–2894 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Bahner, I. et al. Lentiviral vector transduction of a dominant-negative rev gene into human CD34(+) hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol. Ther. 15, 76–85 (2007).
  Article CAS PubMed Google Scholar
• Kohn, D.B. et al. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 94, 368–371 (1999).
  CAS PubMed Google Scholar
• Anderson, J. et al. Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu mouse-derived T cells. Mol. Ther. 15, 1182–1188 (2007).
  Article CAS PubMed Google Scholar
• Morgan, R.A. et al. Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals. Hum. Gene Ther. 16, 1065–1074 (2005).
  Article CAS PubMed Google Scholar
• Hugle, T. & Cerny, A. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev. Med. Virol. 13, 361–371 (2003).
  Article CAS PubMed Google Scholar
• McHutchison, J.G. et al. A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. J. Hepatol. 44, 88–96 (2006).
  Article CAS PubMed Google Scholar